Health ❯ Healthcare ❯ Vaccines

mRNA Technology

Pandemic Preparedness Vaccine Development COVID-19 Vaccines Public Health Cancer Applications Cancer Treatment Public Health Risks Public Health Decisions COVID-19 Public Health Policy Cancer Vaccines Operation Warp Speed Flu Vaccines Moderna Regulatory Affairs Personalized Medicine Moderna Vaccines COVID-19 Response Cancer Research Adverse Effects

FDA to Review Moderna’s Flu Shot as Shares Rally on Earnings Beat

The review sets a decision deadline of August 5, 2026, signaling progress in Moderna’s shift toward a seasonal vaccine strategy.

HHS Axes $500 Million in BARDA mRNA Vaccine Projects, Drawing Intensifying Warnings

RFK Jr. Pulls $500M From mRNA Vaccine Projects, Draws Sharp Criticism